|
|
|
| COMBINED HEPATITIS A |
||
| HEPATITIS
B VACCINE |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
| · | Approved by
the FDA in United States for persons >18 |
|||||||||||
| years old |
||||||||||||
| · | Contains 720
EL.U. hepatitis A antigen and |
|||||||||||
| 20
μg. HBsAg |
||||||||||||
| · | Vaccination
schedule: 0,1,6 months |
|||||||||||
| · | Immunogenicity
similar to single-antigen vaccines |
|||||||||||
| given
separately |
||||||||||||
| · | Can be used
in persons > 18 years old who need |
|||||||||||
| vaccination
against both hepatitis A and B |
||||||||||||
| · | Formulation
for children available in many other |
|||||||||||
| countries |
||||||||||||